Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence of neurovascular diseases such as brain aneurysm, Arteriovenous Malformations (AVMs), and others, are likely to propel the ICP monitoring market
4.2.2 Favourable reimbursement policies provide favourable background for the market growth
4.2.3 Growing prevalence of traumatic brain injuries
4.2.4 Ongoing product development & commercialization will boost the ICP monitoring market
4.3 Restraints
4.3.1 The shortage of trained professionals
4.3.2 High procedural cost of ICP monitoring devices
4.4 Opportunities
4.4.1 Increasing use of endovascular embolization for the treatment of brain aneurysm
4.5 Macroeconomic indicators
5 Market factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D & Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter's Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Re-Operation Rate Analysis
5.4 Complication Rate Analysis
6 Global Intracranial Pressure (ICP) Monitoring Market, By Route of Intervention
6.1 Introduction
6.2 Intraventricular
6.3 Epidural Sensor
7 Global Intracranial Pressure (ICP) Monitoring Market, By Technique
7.1 Introduction
7.2 Invasive
7.3 Non-invasive
7.3.1 Transcranial Doppler Ultrasonography
7.3.2 Tympanic Membrane Displacement (TMD) Analyzer
7.3.3 Optic Nerve Sheath Diameter Sonography
7.3.4 Fundoscopy (Papilledema)
7.3.5 MRI/CT
8 Global Intracranial Pressure (ICP) Monitoring Market, By Application
8.1 Introduction
8.2 Traumatic Brain Injury
8.3 Intracerebral Hemorrhage
8.4 Subarachnoid Hemorrhage
8.5 Meningitis
9 Global Intracranial Pressure (ICP) Monitoring Market, By Device
9.1 Introduction
9.2 Intraventricular catheter
9.3 Subarachnoid screw
9.4 Non-invasive ICP monitors
9.5 Epidural sensors
10 Global Intracranial Pressure (ICP) Monitoring Market, By End User
10.1 Introduction
10.2 Hospitals & Clinic
10.3 Trauma centers
11 Global Intracranial Pressure (ICP) Monitoring Market: by Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.2.1.1 U.S
11.2.1.2 Canada
11.2.2 South America
11.3 Europe
11.3.1 Western Europe
11.3.1.1 Germany
11.3.1.2 France
11.3.1.3 U.K
11.3.1.4 Italy
11.3.1.5 Spain
11.3.1.6 Rest of Western Europe
11.3.2 Eastern Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Rest of Asia Pacific
11.5 Middle East & Africa
11.5.1 Middle East
11.5.2 Africa
11.5.3 Rest of Middle East & Africa
12 Competitive Landscape
12.1 Company Market Share Analysis
12.1.1 Introduction
12.2 Competitive Landscape
12.2.1 Introduction
12.3 Key Developments
13 Company Profiles
13.1 Integra LifeSciences Corporation
13.1.1 Company Overview
13.1.2 Financial Overview
13.1.3 Products Offering
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.1.6 Key Strategy
13.2 DePuy Synthes
13.2.1 Company Overview
13.2.2 Financial Overview
13.2.3 Products Offering
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.2.6 Key Strategy
13.3 Spiegelberg GmbH & Co. KG
13.3.1 Company Overview
13.3.2 Financial Overview
13.3.3 Products Offering
13.3.4 Key Developments
13.3.5 SWOT Analysis
13.3.6 Key Strategy
13.4 RAUMEDIC Inc
13.4.1 Company Overview
13.4.2 Financial Overview
13.4.3 Products Offering
13.4.4 Key Developments
13.4.5 SWOT Analysis
13.4.6 Key Strategy
13.5 Sophysa SA
13.5.1 Company Overview
13.5.2 Financial Overview
13.5.3 Products Offering
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.5.6 Key Strategy
13.6 Boston Neurosciences
13.6.1 Company Overview
13.6.2 Financial Overview
13.6.3 Products Offering
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.6.6 Key Strategy
13.7 Medtronic Plc
13.7.1 Company Overview
13.7.2 Financial Overview
13.7.3 Products Offering
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.7.6 Key Strategy
13.8 Terumo Corporation
13.8.1 Company Overview
13.8.2 Financial Overview
13.8.3 Products Offering
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.8.6 Key Strategy
13.9 Natus Medical Incorporated
13.9.1 Company Overview
13.9.2 Financial Overview
13.9.3 Products Offering
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.9.6 Key Strategy
14 Appendix
14.1 Discussion Blue Print